Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Bosentan May Prolong Survival in Portopulmonary Hypertension
Link ID 1349
Title Bosentan May Prolong Survival in Portopulmonary Hypertension
Url http://www.medscape.com/viewarticle/566904?src=rss
Description In cirrhotic patients with well preserved liver function and severe portopulmonary hypertension (PPHT), treatment with bosentan appears to improve clinical status and offer a survival advantage, German researchers report. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Dec 5, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Warfarin Use Not Associated With Osteoporosis Risk in Men
  Warfarin use does not appear to increase the risk of osteoporosis in elderly men, according to a report in the July issue of the Journal of the American Geriatrics Society. Reuters Health Information
Category:   Articles > Pharmacists


2. Incidence of Infections Associated With Leflunomide for RA "Acceptable"
  Among patients with rheumatoid arthritis (RA) in New Zealand, the rate of serious infection associated with leflunomide treatment is "acceptable in the context of optimally treating active RA," report Dr. Peter T. Chapman of Christchurch Hospital and colleagues in the November issue of the Journal of Rheumatology. Reuters Health Information
Category:   Articles > Pharmacists


3. Ritonavir-Lopinavir Regimen Causes 10-Fold Reduction in HIV Load in CSF
  A regimen of lopinavir plus ritonavir (LPV-rtv) alone for three weeks reduces HIV RNA in cerebrospinal fluid (CSF) by a factor of ten in most HIV-infected patients. Reuters Health Information
Category:   Articles > Pharmacists


4. Newer Antipsychotics Ineffective for Psychosis, Aggression in Alzheimer Disease
  Second-generation antipsychotics (SGAs) are no better than placebo from a cost-benefit viewpoint for treating psychosis and aggression in Alzheimer disease patients, according to a report in the November issue of the Archives of General Psychiatry. Reuters Health Information
Category:   Articles > Pharmacists


5. Second-Generation Antipsychotics Produce Fewer Side Effects
  Second-generation antipsychotics administered by intramuscular injection are efficacious in reducing agitation and are less likely to cause extrapyramidal adverse effects compared with first-generation antipsychotics, according to study findings published in the December issue of the Journal of Clinical Psychiatry. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS